TumorGlow Intraoperative Molecular Imaging (IMI)
ConditionTumor, Solid
Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Pennsylvania
About this trial
This is a Phase 1/2 study in patients presenting with any solid tumor and/or diseased tissue even benign nodules presumed to be resectable and at risk for recurrence on pre-operative assessment who are considered to be good surgical candidates to evaluate the safety and efficacy of the image-guided surgery using indocyanine green for intramolecular imaging of solid tumors.
Eligibility criteria
Qualifiers
Adult patients 18 years of age or older.
Patients presenting with any solid tumor and/or diseased tissue even benign nodules presumed to be resectable and at risk for recurrence on pre-operative assessment.
Good operative candidate as determined by the treating physician and/or multidisciplinary team.
Subject capable of giving informed consent.
Disqualifiers
Subject unable to participate in the consent process.
Vulnerable population including pregnant women, prisoners, and children.
History of uncontrolled hypertension (e.g., history of an ER admission for hypertensive crisis or ≥ 3 blood pressure medications)
Patients with a self-reported history of iodide allergies.
Trial design
Treatments tested in this trial
- Indocyanine Green
Treatment groups
500 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov